
Dr. Francis Collins, director of the National Institutes of Health, said he was “surprised” by the media uproar on treatment guidelines for convalescent plasma for Covid-19, in a tweet Tuesday evening.
“Surprised by media uproar on Treatment Guidelines on convalescent plasma for #COVID19,” the tweet said.
Collins went on to say that the guidelines mirror an emergency use authorization; that the EUA says “CP should not be considered new standard of care,” and provided a link to the EUA.
“No news here,” Collins concluded his tweet.
Some background: An NIH panel said yesterday there's no evidence backing the use of convalescent plasma to treat coronavirus patients and that doctors should not treat it as a standard of care until more study has been done.
"There are insufficient data to recommend either for or against the use of convalescent plasma for the treatment of COVID-19," the panel of more than three dozen experts said in a statement posted on the NIH website Tuesday.
The statement, which was posted quietly, contradicts the Trump Administration's characterization of the treatment as "historic" and a "major advance" and directly refers to last week's emergency use authorization by the US Food and Drug Administration.











